Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board

By sjmartinez • June 27, 2024

Chawla SP, VAN Tine B, Federman N, Schwab J, Jones R, Subbiah V, Chawla NS, Afshar N, Hoos W, Feldman N, Spencer HT, Swaney W, Gordon EM. Proceedings of the Think Tank for Osteosarcoma Medical Advisory Board. Anticancer Res. 2024 Jul;44(7):2765-2768. doi: 10.21873/anticanres.17139. PMID: 38925853.

Tags: cancer stem cell, CAR-T cell therapy, DeltaRex-G, Gene therapy, Hematology/Oncology, immunotherapy, osteosarcoma, personalized medicine, Publications, repurposed drugs, review

Related Posts

US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan

Rugo H, Bardia A, Bruno DS, Ernani V, Hamilton E, Heist R, Jhaveri K, Levy B, Lisberg A, O'Shaughnessy J, Sands J, Spira A, Tolaney[...]

Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial

Melisi D, Macarulla T, De La Fouchardière C, Pazo Cid RA, Chandana SR, Kiss I, Lee WJ, Goetze TO, Van Cutsem E, Paulson AS, Bekaii-Saab[...]

Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study

Milhem MM, Zakharia Y, Davar D, Buchbinder EI, Medina T, Daud A, Ribas A, Chmielowski B, Niu J, Gibney GT, Margolin K, Olszanski AJ, Mehmi[...]